Strategies to minimize hypertrophy in cartilage engineering and regeneration

Genes and Diseases

Volumn 2, Issue 1, 2015, Pages 76-95

  Chen, Song ^a,b   Fu, Peiliang ^b   Cong, Ruijun ^c   Wu, HaiShan ^b   Pei, Ming ^a,d  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c TONGJI UNIVERSITY   (China)

^d West Virginia University   (United States)

Author keywords

Adult stem cell; Cartilage regeneration; Cartilage repair; Cartilage tissue engineering; Chondrogenesis; Hypertrophy

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHONDROITIN SULFATE; HISTONE DEACETYLASE 4; HYPOXIA INDUCIBLE FACTOR; INTEGRIN; ION CHANNEL; MICRORNA; MICRORNA 140; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICULAR CARTILAGE; BIOMECHANICS; CARTILAGE CELL; CARTILAGE MATRIX; CARTILAGE PROGENITOR CELL; CHONDROGENESIS; CHONDROGENIC HYPERTROPHY; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; HUMAN; HYPERTROPHY; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOPHYTE; PRACTICE GUIDELINE; REVIEW; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84978069710     PISSN: None     EISSN: 23523042     Source Type: Journal    
DOI: 10.1016/j.gendis.2014.12.003     Document Type: Review

References (243)

1. Johnstone B., Alini M., Cucchiarini M., et al. Tissue engineering for articular cartilage repair-the state of the art. Eur Cell Mater 2013, 25:248-267.
2. Mahmoudifar N., Doran P.M. Chondrogenesis and cartilage tissue engineering: the longer road to technology development. Trends Biotechnol 2012, 30:166-176.
3. Falah M., Nierenberg G., Soudry M., Hayden M., Volpin G. Treatment of articular cartilage lesions of the knee. Int Orthop 2010, 34:621-630.
4. Ahmed T.A., Hincke M.T. Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng Part B Rev 2010, 16:305-329.
5. Karnes J., Zhang Y., Pei M. Cell therapy for the creation of cartilage and related clinical trials. Gene and Cell Therapy: Therapeutic Mechanisms and Strategies 2015, 1123-1135. Taylor & Francis/CRC Press. 4th ed. N.S. Templeton (Ed.).
6. Hubka K.M., Dahlin R.L., Meretoja V.V., Kasper F.K., Mikos A.G. Enhancing chondrogenic phenotype for cartilage tissue engineering: monoculture and coculture of articular chondrocytes and mesenchymal stem cells. Tissue Eng Part B Rev 2014, 20:641-654.
7. Hennig T., Lorenz H., Thiel A., et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 2007, 211:682-691.
8. Mueller M.B., Tuan R.S. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 2008, 58:1377-1388.
9. Studer D., Millan C., Ozturk E., Maniura-Weber K., Zenobi-Wong M. Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. Eur Cell Mater 2012, 24:118-135. discussion 135.
10. Bush P.G., Parisinos C.A., Hall A.C. The osmotic sensitivity of rat growth plate chondrocytes in situ; clarifying the mechanisms of hypertrophy. J Cell Physiol 2008, 214:621-629.
11. Chao P.H., West A.C., Hung C.T. Chondrocyte intracellular calcium, cytoskeletal organization, and gene expression responses to dynamic osmotic loading. Am J Physiol Cell Physiol 2006, 291:C718-C725.
12. Mackie E.J., Tatarczuch L., Mirams M. The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification. J Endocrinol 2011, 211:109-121.
13. Wang F., Zhu Y. Aquaporin-1: a potential membrane channel for facilitating the adaptability of rabbit nucleus pulposus cells to an extracellular matrix environment. J Orthop Sci 2011, 16:304-312.
14. Hellingman C.A., Koevoet W., van Osch G.J. Can one generate stable hyaline cartilage from adult mesenchymal stem cells? A developmental approach. J Tissue Eng Reg Med 2012, 6:e1-e11.
15. Arnold M.A., Kim Y., Czubryt M.P., et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 2007, 12:377-389.
16. Yoshida C.A., Yamamoto H., Fujita T., et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 2004, 18:952-963.
17. Kwon T.G., Zhao X., Yang Q., et al. Physical and functional interactions between Runx2 and HIF-1alpha induce vascular endothelial growth factor gene expression. J Cell Biochem 2011, 112:3582-3593.
18. Fosang A.J., Last K., Knauper V., Murphy G., Neame P.J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996, 380:17-20.
19. Shen G. The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage. Orthod Craniofac Res 2005, 8:11-17.
20. Anderson H.C. Matrix vesicles and calcification. Curr Rheumatol Rep 2003, 5:222-226.
21. van Donkelaar C.C., Huiskes R. The PTHrP-Ihh feedback loop in the embryonic growth plate allows PTHrP to control hypertrophy and Ihh to regulate proliferation. Biomech Model Mechanobiol 2007, 6:55-62.
22. Iannotti J.P., Naidu S., Noguchi Y., Hunt R.M., Brighton C.T. Growth plate matrix vesicle biogenesis. The role of intracellular calcium. Clin Orthop Relat Res 1994, 222-229.
23. Ortega N., Behonick D.J., Werb Z. Matrix remodeling during endochondral ossification. Trends Cell Biol 2004, 14:86-93.
24. Ortega N., Behonick D., Stickens D., Werb Z. How proteases regulate bone morphogenesis. Ann N Y Acad Sci 2003, 995:109-116.
25. Caplan A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005, 11:1198-1211.
26. Pizzute T., Lynch K., Pei M. Impact of tissue-specific stem cells on lineage-specific differentiation: a focus on the musculoskeletal system. Stem Cell Rev 2014, 10.1007/s12015-014-9546-8.
27. Jones B.A., Pei M. Synovium-derived stem cells: a tissue-specific stem cell for cartilage engineering and regeneration. Tissue Eng Part B Rev 2012, 18:301-311.
28. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New Engl J Med 1994, 331:889-895.
29. Cournil-Henrionnet C., Huselstein C., Wang Y., et al. Phenotypic analysis of cell surface markers and gene expression of human mesenchymal stem cells and chondrocytes during monolayer expansion. Biorheology 2008, 45:513-526.
30. Benya P.D., Shaffer J.D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982, 30:215-224.
31. Jakob M., Demarteau O., Schafer D., et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation invitro. J Cell Biochem 2001, 81:368-377.
32. Wolf F., Candrian C., Wendt D., et al. Cartilage tissue engineering using pre-aggregated human articular chondrocytes. Eur Cell Mater 2008, 16:92-99.
33. Tew S.R., Clegg P.D. Analysis of post transcriptional regulation of SOX9 mRNA during invitro chondrogenesis. Tissue Eng Part A 2011, 17:1801-1807.
34. Peterson L., Minas T., Brittberg M., Nilsson A., Sjogren-Jansson E., Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res 2000, 374:212-234.
35. Roberts S., McCall I.W., Darby A.J., et al. Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology. Arthritis Res Ther 2003, 5:R60-R73.
36. Dowthwaite G.P., Bishop J.C., Redman S.N., et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004, 117:889-897.
37. Hattori S., Oxford C., Reddi A.H. Identification of superficial zone articular chondrocyte stem/progenitor cells. Biochem Biophys Res Commun 2007, 358:99-103.
38. Khan I.M., Bishop J.C., Gilbert S., Archer C.W. Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. Osteoarthr Cartil 2009, 17:518-528.
39. Williams R., Khan I.M., Richardson K., et al. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One 2010, 5:e13246.
40. Yu Y., Zheng H., Buckwalter J.A., Martin J.A. Single cell sorting identifies progenitor cell population from full thickness bovine articular cartilage. Osteoarthr Cartil 2014, 22:1318-1326.
41. McCarthy H.E., Bara J.J., Brakspear K., Singhrao S.K., Archer C.W. The comparison of equine articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for cartilage repair in the horse. Vet J 2012, 192:345-351.
42. Zhou C., Zheng H., Seol D., Yu Y., Martin J.A. Gene expression profiles reveal that chondrogenic progenitor cells and synovial cells are closely related. J Orthop Res 2014, 32:981-988.
43. Mathur D., Pereira W.C., Anand A. Emergence of chondrogenic progenitor stem cells in transplantation biology-prospects and drawbacks. J Cell Biochem 2012, 113:397-403.
44. Sokolove J., Lepus C.M. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 2013, 5:77-94.
45. Garcia-Arnandis I., Guillen M.I., Gomar F., Pelletier J.P., Martel-Pelletier J., Alcaraz M.J. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1beta in osteoarthritic synoviocytes. Arthritis Res Ther 2010, 12:R165.
46. Karlsson C., Emanuelsson K., Wessberg F., et al. Human embryonic stem cell-derived mesenchymal progenitors-potential in regenerative medicine. Stem Cell Res 2009, 3:39-50.
47. Jukes J.M., Both S.K., Leusink A., Sterk L.M., van Blitterswijk C.A., de Boer J. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA 2008, 105:6840-6845.
48. He F., Chen X., Pei M. Reconstruction of an invitro tissue-specific microenvironment to rejuvenate synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A 2009, 15:3809-3821.
49. Pei M., He F., Kish V.L. Expansion on extracellular matrix deposited by human bone marrow stromal cells facilitates stem cell proliferation and tissue-specific lineage potential. Tissue Eng Part A 2011, 17:3067-3076.
50. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
51. Taipaleenmaki H., Suomi S., Hentunen T., Laitala-Leinonen T., Saamanen A.M. Impact of stromal cell composition on BMP-induced chondrogenic differentiation of mouse bone marrow derived mesenchymal cells. Exp Cell Res 2008, 314:2400-2410.
52. Mueller M.B., Fischer M., Zellner J., et al. Effect of parathyroid hormone-related protein in an invitro hypertrophy model for mesenchymal stem cell chondrogenesis. Int Orthop 2013, 37:945-951.
53. Shintani N., Siebenrock K.A., Hunziker E.B. TGF-ss1 enhances the BMP-2-induced chondrogenesis of bovine synovial explants and arrests downstream differentiation at an early stage of hypertrophy. PLoS One 2013, 8:e53086.
54. Bertram H., Boeuf S., Wachters J., et al. Matrix metalloprotease inhibitors suppress initiation and progression of chondrogenic differentiation of mesenchymal stromal cells invitro. Stem Cells Dev 2009, 18:881-892.
55. Lee J.M., Kim J.D., Oh E.J., Oh S.H., Lee J.H., Im G.I. PD98059-impregnated functional PLGA scaffold for direct tissue engineering promotes chondrogenesis and prevents hypertrophy from mesenchymal stem cells. Tissue Eng Part A 2014, 20:982-991.
56. Lengner C.J., Hassan M.Q., Serra R.W., et al. Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation. J Biol Chem 2005, 280:15872-15879.
57. Pei M., Chen D., Li J., Wei L. Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. Differentiation 2009, 78:260-268.
58. Ben-Eliezer M., Phillip M., Gat-Yablonski G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 2007, 32:235-244.
59. Mikami Y., Asano M., Honda M.J., Takagi M. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells. J Cell Physiol 2010, 223:123-133.
60. Kronenberg H.M. PTHrP and skeletal development. Ann N Y Acad Sci 2006, 1068:1-13.
61. Kim Y.J., Kim H.J., Im G.I. PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs. Biochem Biophys Res Commun 2008, 373:104-108.
62. Kafienah W., Mistry S., Dickinson S.C., Sims T.J., Learmonth I., Hollander A.P. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum 2007, 56:177-187.
63. Lee J.M., Im G.I. PTHrP isoforms have differing effect on chondrogenic differentiation and hypertrophy of mesenchymal stem cells. Biochem Biophys Res Commun 2012, 421:819-824.
64. Mello M.A., Tuan R.S. Effects of TGF-beta1 and triiodothyronine on cartilage maturation: invitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res 2006, 24:2095-2105.
65. Cals F.L., Hellingman C.A., Koevoet W., Baatenburg de Jong R.J., van Osch G.J. Effects of transforming growth factor-beta subtypes on invitro cartilage production and mineralization of human bone marrow stromal-derived mesenchymal stem cells. J Tissue Eng Reg Med 2012, 6:68-76.
66. Pei M., He F., Li J., Tidwell J.E., Jones A.C., McDonough E.B. Repair of large animal partial-thickness cartilage defects through intraarticular injection of matrix-rejuvenated synovium-derived stem cells. Tissue Eng Part A 2013, 19:1144-1154.
67. Mueller M.B., Fischer M., Zellner J., et al. Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs 2010, 192:158-166.
68. Narcisi R., Signorile L., Verhaar J.A., Giannoni P., van Osch G.J. TGFbeta inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes. Osteoarthr Cartil 2012, 20:1152-1160.
69. Narcisi R., Quarto R., Ulivi V., Muraglia A., Molfetta L., Giannoni P. TGF beta-1 administration during exvivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. J Cell Physiol 2012, 227:3282-3290.
70. Shen B., Wei A., Tao H., Diwan A.D., Ma D.D. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 2009, 15:1311-1320.
71. Miljkovic N.D., Cooper G.M., Marra K.G. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthr Cartil 2008, 16:1121-1130.
72. Caron M.M., Emans P.J., Cremers A., et al. Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. Osteoarthr Cartil 2013, 21:604-613.
73. Shen B., Bhargav D., Wei A., et al. BMP-13 emerges as a potential inhibitor of bone formation. Int J Biol Sci 2009, 5:192-200.
74. Retting K.N., Song B., Yoon B.S., Lyons K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136:1093-1104.
75. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
76. van der Kraan P.M., Blaney Davidson E.N., Blom A., Van Den Berg W.B. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthr Cartil 2009, 17:1539-1545.
77. Yu P.B., Hong C.C., Sachidanandan C., et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008, 4:33-41.
78. Wu C.W., Tchetina E.V., Mwale F., et al. Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res 2002, 17:639-651.
79. Bobick B.E., Kulyk W.M. Regulation of cartilage formation and maturation by mitogen-activated protein kinase signaling. Birth Defects Res C Embryo Today 2008, 84:131-154.
80. Kim H.J., Im G.I. The effects of ERK1/2 inhibitor on the chondrogenesis of bone marrow- and adipose tissue-derived multipotent mesenchymal stromal cells. Tissue Eng Part A 2010, 16:851-860.
81. Wang G., Beier F. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis. J Bone Miner Res 2005, 20:1022-1031.
82. Jungmann P.M., Mehlhorn A.T., Schmal H., Schillers H., Oberleithner H., Sudkamp N.P. Nanomechanics of human adipose-derived stem cells: small GTPases impact chondrogenic differentiation. Tissue Eng Part A 2012, 18:1035-1044.
83. Zhu S., Lu P., Liu H., et al. Inhibition of Rac1 activity by controlled release of NSC23766 from chitosan microspheres effectively ameliorates osteoarthritis development invivo. Ann Rheum Dis 2015, 74:285-293.
84. Zhu S., Chen P., Wu Y., et al. Programmed application of transforming growth factor beta3 and Rac1 inhibitor NSC23766 committed hyaline cartilage differentiation of adipose-derived stem cells for osteochondral defect repair. Stem Cells Transl Med 2014, 3:1242-1251.
85. Nishigaki F., Sakuma S., Ogawa T., Miyata S., Ohkubo T., Goto T. FK506 induces chondrogenic differentiation of clonal mouse embryonic carcinoma cells, ATDC5. Eur J Pharmacol 2002, 437:123-128.
86. van der Windt A.E., Jahr H., Farrell E., Verhaar J.A., Weinans H., van Osch G.J. Calcineurin inhibitors promote chondrogenic marker expression of dedifferentiated human adult chondrocytes via stimulation of endogenous TGFbeta1 production. Tissue Eng Part A 2010, 16:1-10.
87. van der Windt A.E., Haak E., Kops N., Verhaar J.A., Weinans H., Jahr H. Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers. Arthritis Rheum 2012, 64:1929-1939.
88. Demoor M., Ollitrault D., Gomez-Leduc T., et al. Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction. Biochim Biophys Acta 2014, 1840:2414-2440.
89. Provot S. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 2006, 133:651-662.
90. Wagner T., Wirth J., Meyer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120.
91. Smits P., Li P., Mandel J., et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 2001, 1:277-290.
92. Tsuchiya H., Kitoh H., Sugiura F., Ishiguro N. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 2003, 301:338-343.
93. Lefebvre V., Li P., de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 1998, 17:5718-5733.
94. Ikeda T., Kamekura S., Mabuchi A., et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004, 50:3561-3573.
95. Venkatesan J.K., Ekici M., Madry H., Schmitt G., Kohn D., Cucchiarini M. SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells. Stem Cell Res Ther 2012, 3:22.
96. Horiki M., Imamura T., Okamoto M., et al. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol 2004, 165:433-445.
97. Nishihara A., Fujii M., Sampath T.K., Miyazono K., Reddi A.H. Bone morphogenetic protein signaling in articular chondrocyte differentiation. Biochem Biophys Res Commun 2003, 301:617-622.
98. Kaiser M., Haag J., Soder S., Bau B., Aigner T. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage invivo and are differentially regulated invitro by interleukin-1beta. Arthritis Rheum 2004, 50:3535-3540.
99. Estrada K.D., Retting K.N., Chin A.M., Lyons K.M. Smad6 is essential to limit BMP signaling during cartilage development. J Bone Miner Res 2011, 26:2498-2510.
100. McKinsey T.A., Zhang C.L., Olson E.N. Signaling chromatin to make muscle. Curr Opin Cell Biol 2002, 14:763-772.
101. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci 2003, 983:84-100.
102. Vega R.B., Matsuda K., Oh J., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119:555-566.
103. Shimizu E., Selvamurugan N., Westendorf J.J., Olson E.N., Partridge N.C. HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J Biol Chem 2010, 285:9616-9626.
104. Shukunami C., Iyama K., Inoue H., Hiraki Y. Spatiotemporal pattern of the mouse chondromodulin-I gene expression and its regulatory role in vascular invasion into cartilage during endochondral bone formation. Int J Dev Biol 1999, 43:39-49.
105. Klinger P., Surmann-Schmitt C., Brem M., et al. Chondromodulin 1 stabilizes the chondrocyte phenotype and inhibits endochondral ossification of porcine cartilage repair tissue. Arthritis Rheum 2011, 63:2721-2731.
106. Mera H., Kawashima H., Yoshizawa T., et al. Chondromodulin-1 directly suppresses growth of human cancer cells. BMC Cancer 2009, 9:166.
107. Peng H., Wright V., Usas A., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002, 110:751-759.
108. Afuwape A.O., Feldmann M., Paleolog E.M. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Ther 2003, 10:1950-1960.
109. Kubo S., Cooper G.M., Matsumoto T., et al. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum 2009, 60:155-165.
110. Matsumoto T., Cooper G.M., Gharaibeh B., et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 2009, 60:1390-1405.
111. Haigh J.J., Gerber H.P., Ferrara N., Wagner E.F. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 2000, 127:1445-1453.
112. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 2004, 131:2161-2171.
113. Wasylyk B., Hagman J., Gutierrez-Hartmann A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 1998, 23:213-216.
114. Iwamoto M., Higuchi Y., Koyama E., et al. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J Cell Biol 2000, 150:27-40.
115. Acharya C., Adesida A., Zajac P., et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. JCell Physiol 2012, 227:88-97.
116. Lettry V., Hosoya K., Takagi S., Okumura M. Coculture of equine mesenchymal stem cells and mature equine articular chondrocytes results in improved chondrogenic differentiation of the stem cells. Jpn J Vet Res 2010, 58:5-15.
117. Aung A., Gupta G., Majid G., Varghese S. Osteoarthritic chondrocyte-secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum 2011, 63:148-158.
118. Bian L., Zhai D.Y., Mauck R.L., Burdick J.A. Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. Tissue Eng Part A 2011, 17:1137-1145.
119. Fischer J., Dickhut A., Rickert M., Richter W. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum 2010, 62:2696-2706.
120. Weiss S., Hennig T., Bock R., Steck E., Richter W. Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 2010, 223:84-93.
121. Mo X.T., Guo S.C., Xie H.Q., et al. Variations in the ratios of co-cultured mesenchymal stem cells and chondrocytes regulate the expression of cartilaginous and osseous phenotype in alginate constructs. Bone 2009, 45:42-51.
122. Meretoja V.V., Dahlin R.L., Kasper F.K., Mikos A.G. Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials 2012, 33:6362-6369.
123. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol 1999, 11:634-640.
124. Girard-Lauriault P.-L., Mwale F., Iordanova M., Demers C., Desjardins P., Wertheimer M.R. Atmospheric pressure deposition of micropatterned nitrogen-rich plasma-polymer films for tissue engineering. Plasma Process Polym 2005, 2:263-270.
125. Petit A., Demers C.N., Girard-Lauriault P.L., et al. Effect of nitrogen-rich cell culture surfaces on type X collagen expression by bovine growth plate chondrocytes. Biomed Eng Online 2011, 10:4.
126. Mwale F., Girard-Lauriault P.L., Wang H.T., Lerouge S., Antoniou J., Wertheimer M.R. Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings. Tissue Eng 2006, 12:2639-2647.
127. Rampersad S., Ruiz J.C., Petit A., et al. Stem cells, nitrogen-rich plasma-polymerized culture surfaces, and type X collagen suppression. Tissue Eng Part A 2011, 17:2551-2560.
128. Li Q., Williams C.G., Sun D.D., Wang J., Leong K., Elisseeff J.H. Photocrosslinkable polysaccharides based on chondroitin sulfate. J Biomed Mater Res A 2004, 68:28-33.
129. Muzzarelli R.A., Greco F., Busilacchi A., Sollazzo V., Gigante A. Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: a review. Carbohydr Polym 2012, 89:723-739.
130. Roughley P., Martens D., Rantakokko J., Alini M., Mwale F., Antoniou J. The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. Eur Cell Mater 2006, 11:1-7. discussion 7.
131. Varghese S., Hwang N.S., Canver A.C., Theprungsirikul P., Lin D.W., Elisseeff J. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol 2008, 27:12-21.
132. Wu Y.N., Yang Z., Hui J.H., Ouyang H.W., Lee E.H. Cartilaginous ECM component-modification of the micro-bead culture system for chondrogenic differentiation of mesenchymal stem cells. Biomaterials 2007, 28:4056-4067.
133. Toh W.S., Foldager C.B., Pei M., Hui J.H. Advances in mesenchymal stem cell-based strategies for cartilage repair and regeneration. Stem Cell Rev 2014, 10:686-696.
134. Badylak S.F., Taylor D., Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Ann Rev Biomed Eng 2011, 13:27-53.
135. Benders K.E., van Weeren P.R., Badylak S.F., Saris D.B., Dhert W.J., Malda J. Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol 2013, 31:169-176.
136. Tottey S., Johnson S.A., Crapo P.M., et al. The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials 2011, 32:128-136.
137. Choi K.H., Choi B.H., Park S.R., Kim B.J., Min B.H. The chondrogenic differentiation of mesenchymal stem cells on an extracellular matrix scaffold derived from porcine chondrocytes. Biomaterials 2010, 31:5355-5365.
138. Pei M., Li J.T., Shoukry M., Zhang Y. A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering. Eur Cell Mater 2011, 22:333-343. discussion 343.
139. Cheng N.C., Estes B.T., Awad H.A., Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells by a porous scaffold derived from native articular cartilage extracellular matrix. Tissue Eng Part A 2009, 15:231-241.
140. Chang C.H., Chen C.C., Liao C.H., Lin F.H., Hsu Y.M., Fang H.W. Human acellular cartilage matrix powders as a biological scaffold for cartilage tissue engineering with synovium-derived mesenchymal stem cells. J Biomed Mater Res A 2014, 102:2248-2257.
141. Li J., Pei M. Optimization of an invitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A 2011, 17:703-712.
142. Jin C.Z., Choi B.H., Park S.R., Min B.H. Cartilage engineering using cell-derived extracellular matrix scaffold invitro. J Biomed Mater Res A 2010, 92:1567-1577.
143. Jin C.Z., Park S.R., Choi B.H., Park K., Min B.H. Invivo cartilage tissue engineering using a cell-derived extracellular matrix scaffold. Artif Organs 2007, 31:183-192.
144. D'Ippolito G., Diabira S., Howard G.A., Roos B.A., Schiller P.C. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 2006, 39:513-522.
145. Ronziere M.C., Perrier E., Mallein-Gerin F., Freyria A.M. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng 2010, 20:145-158.
146. Xu Y., Malladi P., Chiou M., Bekerman E., Giaccia A.J., Longaker M.T. Invitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogenesis. Tissue Eng 2007, 13:2981-2993.
147. Sheehy E.J., Buckley C.T., Kelly D.J. Oxygen tension regulates the osteogenic, chondrogenic and endochondral phenotype of bone marrow derived mesenchymal stem cells. Biochem Biophys Res Commun 2012, 417:305-310.
148. Hirao M., Tamai N., Tsumaki N., Yoshikawa H., Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006, 281:31079-31092.
149. Kawato Y., Hirao M., Ebina K., et al. Nkx3.2-induced suppression of Runx2 is a crucial mediator of hypoxia-dependent maintenance of chondrocyte phenotypes. Biochem Biophys Res Commun 2011, 416:205-210.
150. Wong M., Siegrist M., Goodwin K. Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hypertrophic markers in primary chondrocytes. Bone 2003, 33:685-693.
151. Bian L., Zhai D.Y., Zhang E.C., Mauck R.L., Burdick J.A. Dynamic compressive loading enhances cartilage matrix synthesis and distribution and suppresses hypertrophy in hMSC-laden hyaluronic acid hydrogels. Tissue Eng Part A 2012, 18:715-724.
152. Ebisawa K., Hata K., Okada K., et al. Ultrasound enhances transforming growth factor beta-mediated chondrocyte differentiation of human mesenchymal stem cells. Tissue Eng 2004, 10:921-929.
153. Cui J.H., Park S.R., Park K., Choi B.H., Min B.H. Preconditioning of mesenchymal stem cells with low-intensity ultrasound for cartilage formation invivo. Tissue Eng 2007, 13:351-360.
154. Li T.F., Dong Y., Ionescu A.M., et al. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res 2004, 299:128-136.
155. Huang W., Zhou X., Lefebvre V., de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 2000, 20:4149-4158.
156. Kozhemyakina E., Cohen T., Yao T.P., Lassar A.B. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol Cell Biol 2009, 29:5751-5762.
157. Zhen X., Wei L., Wu Q., Zhang Y., Chen Q. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem 2001, 276:4879-4885.
158. Stanton L.A., Sabari S., Sampaio A.V., Underhill T.M., Beier F. p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 2004, 378:53-62.
159. Han Y.S., Bang O.S., Jin E.J., Park J.H., Sonn J.K., Kang S.S. High dose of glucose promotes chondrogenesis via PKCalpha and MAPK signaling pathways in chick mesenchymal cells. Cell Tissue Res 2004, 318:571-578.
160. Li Y., Ahrens M.J., Wu A., Liu J., Dudley A.T. Calcium/calmodulin-dependent protein kinase II activity regulates the proliferative potential of growth plate chondrocytes. Development 2011, 138:359-370.
161. Zhang M., Xie R., Hou W., et al. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation. J Cell Sci 2009, 122:1382-1389.
162. Zeng L., Kempf H., Murtaugh L.C., Sato M.E., Lassar A.B. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 2002, 16:1990-2005.
163. Kobayashi T., Soegiarto D.W., Yang Y., et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 2005, 115:1734-1742.
164. Mak K.K., Kronenberg H.M., Chuang P.T., Mackem S., Yang Y. Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 2008, 135:1947-1956.
165. Matta C., Fodor J., Szijgyarto Z., et al. Cytosolic free Ca2+ concentration exhibits a characteristic temporal pattern during invitro cartilage differentiation: a possible regulatory role of calcineurin in Ca-signalling of chondrogenic cells. Cell Calcium 2008, 44:310-323.
166. Chang W., Tu C., Chen T.H., et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999, 140:5883-5893.
167. Wu S., Palese T., Mishra O.P., Delivoria-Papadopoulos M., De Luca F. Effects of Ca2+ sensing receptor activation in the growth plate. FASEB J 2004, 18:143-145.
168. D'Andrea P., Calabrese A., Capozzi I., Grandolfo M., Tonon R., Vittur F. Intercellular Ca2+ waves in mechanically stimulated articular chondrocytes. Biorheology 2000, 37:75-83.
169. Steward A.J., Kelly D.J., Wagner D.R. The role of calcium signalling in the chondrogenic response of mesenchymal stem cells to hydrostatic pressure. Eur Cell Mater 2014, 28:358-371.
170. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 2006, 116:1853-1864.
171. Bassik M.C., Scorrano L., Oakes S.A., Pozzan T., Korsmeyer S.J. Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J 2004, 23:1207-1216.
172. Orfanidou T., Malizos K.N., Varitimidis S., Tsezou A. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes. Exp Biol Med 2012, 237:241-253.
173. Hellingman C.A., Davidson E.N., Koevoet W., et al. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 2011, 17:1157-1167.
174. Furumatsu T., Tsuda M., Taniguchi N., Tajima Y., Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005, 280:8343-8350.
175. Kang J.S., Alliston T., Delston R., Derynck R. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J 2005, 24:2543-2555.
176. Konrad L., Scheiber J.A., Bergmann M., Eickelberg O., Hofmann R. Identification of a new human Smad6 splice variant. Andrologia 2008, 40:358-363.
177. Scharstuhl A., Diepens R., Lensen J., et al. Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGF-beta-mediated chondrocyte proliferation and proteoglycan synthesis. Osteoarthr Cartil 2003, 11:773-782.
178. Ying S.X., Hussain Z.J., Zhang Y.E. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem 2003, 278:39029-39036.
179. Lin X., Liang M., Feng X.H. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 2000, 275:36818-36822.
180. Wu Q., Chen D., Zuscik M.J., O'Keefe R.J., Rosier R.N. Overexpression of Smurf2 stimulates endochondral ossification through upregulation of beta-catenin. J Bone Miner Res 2008, 23:552-563.
181. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009, 10:468-477.
182. Ma B., Landman E.B., Miclea R.L., et al. WNT signaling and cartilage: of mice and men. Calcif Tissue Int 2013, 92:399-411.
183. Dong Y.F., Soung do Y., Schwarz E.M., O'Keefe R.J., Drissi H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 2006, 208:77-86.
184. Topol L., Chen W., Song H., Day T.F., Yang Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 2009, 284:3323-3333.
185. Yano F., Kugimiya F., Ohba S., et al. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun 2005, 333:1300-1308.
186. Im G.I., Lee J.M., Kim H.J. Wnt inhibitors enhance chondrogenesis of human mesenchymal stem cells in a long-term pellet culture. Biotechnol Lett 2011, 33:1061-1068.
187. Bradley E.W., Drissi M.H. WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol Endocrinol 2010, 24:1581-1593.
188. Leijten J.C., Emons J., Sticht C., et al. Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum 2012, 64:3302-3312.
189. Gelse K., Ekici A.B., Cipa F., et al. Molecular differentiation between osteophytic and articular cartilage-clues for a transient and permanent chondrocyte phenotype. Osteoarthr Cartil 2012, 20:162-171.
190. Leijten J.C., Bos S.D., Landman E.B., et al. GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors. Arthritis Res Ther 2013, 15:R126.
191. Gazzerro E., Smerdel-Ramoya A., Zanotti S., et al. Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J Biol Chem 2007, 282:31549-31557.
192. Stanton L.A., Underhill T.M., Beier F. MAP kinases in chondrocyte differentiation. Dev Biol 2003, 263:165-175.
193. Pearson G., Robinson F., Beers Gibson T., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22:153-183.
194. Xiao G., Gopalakrishnan R., Jiang D., Reith E., Benson M.D., Franceschi R.T. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002, 17:101-110.
195. Provot S., Nachtrab G., Paruch J., Chen A.P., Silva A., Kronenberg H.M. A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes. Mol Cell Biol 2008, 28:344-357.
196. Appleton C.T., Usmani S.E., Mort J.S., Beier F. Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation. Lab Invest 2010, 90:20-30.
197. Kanichai M., Ferguson D., Prendergast P.J., Campbell V.A. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. J Cell Physiol 2008, 216:708-715.
198. Robins J.C., Akeno N., Mukherjee A., et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 2005, 37:313-322.
199. Strobel S., Loparic M., Wendt D., et al. Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages. Arthritis Res Ther 2010, 12:R34.
200. Adesida A.B., Mulet-Sierra A., Jomha N.M. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Stem Cell Res Ther 2012, 3:9.
201. Lafont J.E., Talma S., Murphy C.L. Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum 2007, 56:3297-3306.
202. Saito T., Fukai A., Mabuchi A., et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010, 16:678-686.
203. Yang S., Kim J., Ryu J.H., et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010, 16:687-693.
204. Colvin J.S., Bohne B.A., Harding G.W., McEwen D.G., Ornitz D.M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996, 12:390-397.
205. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996, 84:911-921.
206. Liu Z., Xu J., Colvin J.S., Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002, 16:859-869.
207. Ohbayashi N., Shibayama M., Kurotaki Y., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002, 16:870-879.
208. Hung I.H., Yu K., Lavine K.J., Ornitz D.M. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev Biol 2007, 307:300-313.
209. Millward-Sadler S.J., Salter D.M. Integrin-dependent signal cascades in chondrocyte mechanotransduction. Ann Biomed Eng 2004, 32:435-446.
210. Amano M., Chihara K., Kimura K., et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997, 275:1308-1311.
211. Xu T., Wu M., Feng J., Lin X., Gu Z. RhoA/Rho kinase signaling regulates transforming growth factor-beta1-induced chondrogenesis and actin organization of synovium-derived mesenchymal stem cells through interaction with the Smad pathway. Int J Mol Med 2012, 30:1119-1125.
212. Wang G., Woods A., Sabari S., Pagnotta L., Stanton L.A., Beier F. RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J Biol Chem 2004, 279:13205-13214.
213. Johnson K.A., Rose D.M., Terkeltaub R.A. Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. J Cell Sci 2008, 121:2256-2264.
214. Tanaka K., Yokosaki Y., Higashikawa F., Saito Y., Eboshida A., Ochi M. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2. Matrix Biol 2007, 26:409-418.
215. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(suppl):245-254.
216. Barter M.J., Bui C., Young D.A. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthr Cartil 2012, 20:339-349.
217. Furumatsu T., Ozaki T. Epigenetic regulation in chondrogenesis. Acta Med Okayama 2010, 64:155-161.
218. Wang A.H., Bertos N.R., Vezmar M., et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 1999, 19:7816-7827.
219. Guan Y., Chen Q., Yang X., et al. Subcellular relocation of histone deacetylase 4 regulates growth plate chondrocyte differentiation through Ca2+/calmodulin-dependent kinase IV. Am J Physiol Cell Physiol 2012, 303:C33-C40.
220. Nishino T.G., Miyazaki M., Hoshino H., Miwa Y., Horinouchi S., Yoshida M. 14-3-3 regulates the nuclear import of class IIa histone deacetylases. Biochem Biophys Res Commun 2008, 377:852-856.
221. Backs J., Backs T., Bezprozvannaya S., McKinsey T.A., Olson E.N. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol 2008, 28:3437-3445.
222. Jensen E.D., Gopalakrishnan R., Westendorf J.J. Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2. J Biol Chem 2009, 284:2225-2234.
223. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001, 107:823-826.
224. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008, 9:219-230.
225. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3:e3740.
226. Miyaki S., Nakasa T., Otsuki S., et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009, 60:2723-2730.
227. Nakamura Y., He X., Kato H., et al. Sox9 is upstream of microRNA-140 in cartilage. Appl Biochem Biotechnol 2012, 166:64-71.
228. Miyaki S., Sato T., Inoue A., et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010, 24:1173-1185.
229. Buechli M.E., Lamarre J., Koch T.G. MicroRNA-140 expression during chondrogenic differentiation of equine cord blood-derived mesenchymal stromal cells. Stem Cells Dev 2013, 22:1288-1296.
230. Quina A.S., Buschbeck M., Di Croce L. Chromatin structure and epigenetics. Biochem Pharmacol 2006, 72:1563-1569.
231. Ezura Y., Sekiya I., Koga H., Muneta T., Noda M. Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum 2009, 60:1416-1426.
232. Zimmermann P., Boeuf S., Dickhut A., Boehmer S., Olek S., Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum 2008, 58:2743-2753.
233. Cheung K.S., Hashimoto K., Yamada N., Roach H.I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int 2009, 29:525-534.
234. Roach H.I., Yamada N., Cheung K.S., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005, 52:3110-3124.
235. El-Serafi A.T., Oreffo R.O., Roach H.I. Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: differential effects of 5-aza-deoxycytidine and trichostatin A. Differentiation 2011, 81:35-41.
236. Houston B., Stewart A.J., Farquharson C. PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone 2004, 34:629-637.
237. Roberts S., Narisawa S., Harmey D., Millan J.L., Farquharson C. Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res 2007, 22:617-627.
238. Balcerzak M., Hamade E., Zhang L., et al. The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochim Pol 2003, 50:1019-1038.
239. Kirsch T., Harrison G., Golub E.E., Nah H.D. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem 2000, 275:35577-35583.
240. Terkeltaub R.A. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 2001, 281:C1-C11.
241. Addison W.N., Azari F., Sorensen E.S., Kaartinen M.T., McKee M.D. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem 2007, 282:15872-15883.
242. Xiao Z., Blonder J., Zhou M., Veenstra T.D. Proteomic analysis of extracellular matrix and vesicles. J Proteomics 2009, 72:34-45.
243. Yamashita S., Andoh M., Ueno-Kudoh H., Sato T., Miyaki S., Asahara H. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 2009, 315:2231-2240.